Skip to main content
Fig. 3 | Annals of Clinical Microbiology and Antimicrobials

Fig. 3

From: An assessment on the role of endophytic microbes in the therapeutic potential of Fagonia indica

Fig. 3

Section labeled as “I” shows antifungal activity of bacterial crude extracts against pathogenic strains (a) Aspergillus niger, (b) Mucor mycosis, (c) Aspergillus fumigatus, (d) Aspergillus flavus. Section “II” indicates protein kinase inhibition activity of bacterial extracts using streptomyces strain as model organism (A represent bald zone, B clear zone and C no zone)

Back to article page
\